Abstract
Human immunodeficiency virus (HIV) infection is arguably the most significant global health problem of the modern era. Infection has all but devastated third-world countries and continues to threaten public health in developed nations. With the numbers of deaths approaching tens of millions each year, the greatest imperative for world health is the realization of an effective preventative vaccine. The major obstacles prohibiting this goal include a better understanding of protective immunity in the natural host of the virus. In working toward this objective, animal model systems were developed to recapitulate disease processes and viral diversity as it occurs in natural infections of man. Nonetheless, HIV is species specific and is diffi- cult to study in animal systems. Transgenic animals have been developed expressing human receptors in order to overcome some of these limitations; but an animal model that can be progressively infected by HIV remains elusive. Thus, a number of animal models have been established that utilize “other” lentiviruses that mimic HIV infection in specific ways and provide the means to mirror natural infection in its human host. Alternatively, relevant animal models replicate aspects of human disease through the engraftment of infected human cells. Ultimately, these animal model systems of HIV disease provide insight into specific disease processes and serve to elucidate underlying mechanisms of infection and subsequent disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aldrovandi, G. M., Feuer, G., Gao, L., Jamieson, B., Kristeva, M., Chen, I. S., and Zack, J. A., 1993, The SCID-hu mouse as a model for HIV-1 infection, Nature. 363:732–736.
Alexander, N. J., 1990, Sexual transmission of human immunodeficiency virus: virus entry into the male and female genital tract. World Health Organization, Global Programme on Acquired Immune Deficiency Syndrome, Fertil Steril. 54:1–18.
Allison, R. W., and Hoover, E. A., 2003, Covert vertical transmission of feline immunodeficiency virus, AIDS Res Hum Retroviruses. 19:421–434.
Allison, R. W., and Hoover, E. A., 2003, Feline immunodeficiency virus is concentrated in milk early in lactation, AIDS Res Hum Retroviruses. 19:245–253.
Altfeld, M., Rosenberg, E. S., Shankarappa, R., Mukherjee, J. S., Hecht, F. M., Eldridge, R. L., Addo, M. M., Poon, S. H., Phillips, M. N., Robbins, G. K., Sax, P. E., Boswell, S., Kahn, J. O., Brander, C., Goulder, P. J., Levy, J. A., Mullins, J. I., and Walker, B. D., 2001, Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection, J Exp Med. 193:169–180.
Apetrei, C., Robertson, D. L., and Marx, P. A., 2004, The history of SIVS and AIDS: epidemiology, phylogeny and biology of isolates from naturally SIV infected non-human primates (NHP) in Africa, Front Biosci. 9:225–254.
Archambault, D., Nadin-Davis, S., Lutze-Wallace, C., and Bouillant, A. M., 1993, The bovine immunodeficiency virus: 1990–1992 update, Vet Res. 24:179–187.
Arthur, L. O., Bess, J. W., Jr., Waters, D. J., Pyle, S. W., Kelliher, J. C., Nara, P. L., Krohn, K., Robey, W. G., Langlois, A. J., Gallo, R. C., and et al., 1989, Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120, J Virol. 63:5046–5053.
Bacchetti, P., and Moss, A. R., 1989, Incubation period of AIDS in San Francisco, Nature. 338:251–253.
Barr, M. C., Billaud, J. N., Selway, D. R., Huitron-Resendiz, S., Osborn, K. G., Henriksen, S. J., and Phillips, T. R., 2000, Effects of multiple acute morphine exposures on feline immunodeficiency virus disease progression, J Infect Dis. 182:725–732.
Barry, S. M., Johnson, M. A., and Janossy, G., 2003, Increased proportions of activated and proliferating memory CD8+ T lymphocytes in both blood and lung are associated with blood HIV viral load, J Acquir Immune Defic Syndr. 34:351–357.
Baszler, T. V., Harwood, W. G., Lester, K. L., Davis, W. C., and Knowles, D. P., 1994, Characterization of caprine microglial cells and in vitro infection with caprine arthritisencephalitis lentivirus, Lab Invest. 70:933–943.
Bendinelli, M., Matteucci, D., and Friedman, H., 1985, Retrovirus-induced acquired immunodeficiencies, Adv Cancer Res. 45:125–181.
Bendinelli, M., Pistello, M., Lombardi, S., Poli, A., Garzelli, C., Matteucci, D., Ceccherini-Nelli, L., Malvaldi, G., and Tozzini, F., 1995, Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen, Clin Microbiol Rev. 8:87–112.
Bogerd, H. P., Wiegand, H. L., Bieniasz, P. D., and Cullen, B. R., 2000, Functional differences between human and bovine immunodeficiency virus tat transcription factors, J Virol. 74:4666–4671.
Bonyhadi, M. L., and Kaneshima, H., 1997, The SCID-hu mouse: an in vivo model for HIV-1 infection in humans, Mol Med Today. 3:246–253.
Borrow, P., Lewicki, H., Hahn, B. H., Shaw, G. M., and Oldstone, M. B., 1994, Virusspecific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection, J Virol. 68:6103–6110.
Browning, J., Horner, J. W., Pettoello-Mantovani, M., Raker, C., Yurasov, S., DePinho, R. A., and Goldstein, H., 1997, Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection, Proc Natl Acad Sci USA. 94:14637–14641.
Cadore, J. L., Greenland, T., Cordier, G., Guiguen, F., and Mornex, J. F., 1996, Histogenesis of the pulmonary lesions in the course of visna maedi virus-induced pneumonia, Vet Res. 27:419–426.
Chargui, J., Dye, D., Blomberg, J., Desgranges, C., and Touraine, J. L., 1995, The humanized severe combined immunodeficient mouse as a model for primary human humoral response against HIV1 peptides, J Immunol Methods. 181:91–100.
Charneau, P., Borman, A. M., Quillent, C., Guetard, D., Chamaret, S., Cohen, J., Remy, G., Montagnier, L., and Clavel, F., 1994, Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group, Virology. 205:247–253.
Chattopadhyay, S. K., Morse, H. C., III, Makino, M., Ruscetti, S. K., and Hartley, J. W., 1989, Defective virus is associated with induction of murine retrovirus-induced immunodeficiency syndrome, Proc Natl Acad Sci USA. 86:3862–3866.
Cheevers, W. P., and McGuire, T. C., 1985, Equine infectious anemia virus: immunopathogenesis and persistence, Rev Infect Dis. 7:83–88.
Clark, S., Duggan, J., and Chakraborty, J., 2001, Tsl and LP-BM5: a comparison of two murine retrovirus models for HIV, Viral Immunol. 14:95–109.
Clavel, F., Guyader, M., Guetard, D., Salle, M., Montagnier, L., and Alizon, M., 1986, Molecular cloning and polymorphism of the human immune deficiency virus type 2, Nature. 324:691–695.
Cohen, N. D., and Carter, G. K., 1991, Persistent thrombocytopenia in a case of equine infectious anemia, J Am Vet Med Assoc. 199:750–752.
Cooper, D. A., Gold, J., Maclean, P., Donovan, B., Finlayson, R., Barnes, T. G., Michelmore, H. M., Brooke, P., and Penny, R., 1985, Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion, Lancet. 1:537–540.
Cordier, G., Cozon, G., Greenland, T., Rocher, F., Guiguen, F., Guerret, S., Brune, J., and Mornex, J. F., 1990, In vivo activation of alveolar macrophages in ovine lentivirus infection, Clin Immunol Immunopathol. 55:355–367.
Cork, L. C., Hadlow, W. J., Crawford, T. B., Gorham, J. R., and Piper, R. C., 1974, Infectious leukoencephalomyelitis of young goats, J Infect Dis. 129:134–141.
Cork, L. C., Hadlow, W. J., Gorham, J. R., Piper, R. C., and Crawford, T. B., 1974, Pathology of viral leukoencephalomyelitis of goats, Acta Neuropathol (Berl). 29:281–292.
Curran, J. W., Lawrence, D. N., Jaffe, H., Kaplan, J. E., Zyla, L. D., Chamberland, M., Weinstein, R., Lui, K. J., Schonberger, L. B., Spira, T. J., et al., 1984, Acquired immunodeficiency syndrome (AIDS) associated with transfusions, N Engl J Med. 310:69–75.
Dalziel, R. G., Hopkins, J., Watt, N. J., Dutia, B. M., Clarke, H. A., and McConnell, I., 1991, Identification of a putative cellular receptor for the lentivirus visna virus, J Gen Virol. 72 (Pt 8):1905–1911.
Dawson, M., 1987, Pathogenesis of maedi-visna, Vet Rec. 120:451–454.
Dickie, P., Felser, J., Eckhaus, M., Bryant, J., Silver, J., Marinos, N., and Notkins, A. L., 1991, HIV-associated nephropathy in transgenic mice expressing HIV-1 genes, Virology. 185:109–119.
Donnelly, C., Leisenring, W., Kanki, P., Awerbuch, T., and Sandberg, S., 1993, Comparison of transmission rates of HIV-1 and HIV-2 in a cohort of prostitutes in Senegal, Bull Math Biol. 55:731–743.
Dormont, D., Livartowski, J., Chamaret, S., Guetard, D., Henin, D., Levagueresse, R., van de Moortelle, P. F., Larke, B., Gourmelon, P., Vazeux, R., et al., 1989, HIV-2 in rhesus monkeys: serological, virological and clinical results, Intervirology. 30Suppl 1:59–65.
Dorrington, R., Bourne, D., Bradshaw, D., Laubscher, R., and Timaeus, I., 2001, Medical Research Council, Tygerber, pp. 1–58.
Douek, D. C., 2003, Disrupting T-cell homeostasis: how HIV-1 infection causes disease, AIDS Rev. 5:172–177.
Douek, D. C., Brenchley, J. M., Betts, M. R., Ambrozak, D. R., Hill, B. J., Okamoto, Y., Casazza, J. P., Kuruppu, J., Kunstman, K., Wolinsky, S., Grossman, Z., Dybul, M., Oxenius, A., Price, D. A., Connors, M., and Koup, R. A., 2002, HIV preferentially infects HIVspecific CD4+ T cells, Nature. 417:95–98.
Dow, S. W., Dreitz, M. J., and Hoover, E. A., 1992, Feline immunodeficiency virus neurotropism: evidence that astrocytes and microglia are the primary target cells, Vet Immunol Immunopathol. 35:23–35.
Flaming, K., van der Maaten, M., Whetstone, C., Carpenter, S., Frank, D., and Roth, J., 1993, Effect of bovine immunodeficiency-like virus infection on immune function in experimentally infected cattle, Vet Immunol Immunopathol. 36:91–105.
Gaillard, P., Melis, R., Mwanyumba, F., Claeys, P., Muigai, E., Mandaliya, K., Bwayo, J., and Temmerman, M., 2002, Vulnerability of women in an African setting: lessons for mother-to-child HIV transmission prevention programmes, Aids. 16:937–939.
Gavrilin, M. A., Mathes, L. E., and Podell, M., 2002, Methamphetamine enhances cell-associated feline immunodeficiency virus replication in astrocytes, J Neurovirol. 8:240–249.
Gazzinelli, R. T., Hartley, J. W., Fredrickson, T. N., Chattopadhyay, S. K., Sher, A., and Morse, H. C., III, 1992, Opportunistic infections and retrovirus-induced immunodeficiency: studies of acute and chronic infections with Toxoplasma gondii in mice infected with LP-BM5 murine leukemia viruses, Infect Immun. 60:4394–4401.
Gendelman, H. E., Narayan, O., Molineaux, S., Clements, J. E., and Ghotbi, Z., 1985, Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow, Proc Natl Acad Sci USA. 82:7086–7090.
Georgsson, G., Martin, J. R., Palsson, P. A., Nathanson, N., Benediktsdottir, E., and Petursson, G., 1979, An ultrastructural study of the cerebrospinal fluid in visna, Acta Neuropathol (Berl). 48:39–43.
Gupta, K. K., 1993, Acute immunosuppression with HIV seroconversion, N Engl J Med. 328:288–289.
Gurtler, L. G., Hauser, P. H., Eberle, J., von Brunn, A., Knapp, S., Zekeng, L., Tsague, J. M., and Kaptue, L., 1994, A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon, J Virol. 68:1581–1585.
Habis, A., Baskin, G. B., Murphey-Corb, M., and Levy, L. S., 1999, Simian AIDSassociated lymphoma in rhesus and cynomolgus monkeys recapitulates the primary pathobiological features of AIDS-associated non-Hodgkin’s lymphoma, AIDS Res Hum Retroviruses. 15:1389–1398.
Hart, A. R., and Cloyd, M. W., 1990, Interference patterns of human immunodeficiency viruses HIV-1 and HIV-2, Virology. 177:1–10.
Heise, C., Vogel, P., Miller, C. J., Halsted, C. H., and Dandekar, S., 1993, Simian immunodeficiency virus infection of the gastrointestinal tract of rhesus macaques. Functional, pathological, and morphological changes, Am J Pathol. 142:1759–1771.
Hotzel, I., and Cheevers, W. P., 2003, Caprine arthritis-encephalitis virus envelope surface glycoprotein regions interacting with the transmembrane glycoprotein: structural and functional parallels with human immunodeficiency virus type 1 gp120, J Virol. 77:11578–11587.
Ilaria, G., Jacobs, J. L., Polsky, B., Koll, B., Baron, P., MacLow, C., Armstrong, D., and Schlegel, P. N., 1992, Detection of HIV-1 DNA sequences in pre-ejaculatory fluid, Lancet. 340:1469.
Issel, C. J., McManus, J. M., Hagius, S. D., Foil, L. D., Adams, W. V., Jr., and Montelaro, R. C., 1990, Equine infectious anemia: prospects for control, Dev Biol Stand. 72:49–57.
Jagger, J., Hunt, E. H., Brand-Elnaggar, J., and Pearson, R. D., 1988, Rates of needlestick injury caused by various devices in a university hospital, N Engl J Med. 319:284–288.
Johnson, P. R., and Hirsch, V. M., 1992, SIV infection of macaques as a model for AIDS pathogenesis, Int Rev Immunol. 8:55–63.
Jolicoeur, P., Laperriere, A., and Beaulieu, N., 1992, Efficient production of human immunodeficiency virus proteins in transgenic mice, J Virol. 66:3904–3908.
Jordan, H. L., Howard, J. G., Bucci, J. G., Butterworth, J. L., English, R., Kennedy-Stoskopf, S., Tompkins, M. B., and Tompkins, W. A., 1998, Horizontal transmission of feline immunodeficiency virus with semen from seropositive cats, J Reprod Immunol. 41:341–357.
Kanki, P. J., Travers, K. U., S, M. B., Hsieh, C. C., Marlink, R. G., Gueye, N. A., Siby, T., Thior, I., Hernandez-Avila, M., Sankale, J. L., et al., 1994, Slower heterosexual spread of HIV-2 than HIV-1, Lancet. 343:943–946.
Keppler, O. T., Welte, F. J., Ngo, T. A., Chin, P. S., Patton, K. S., Tsou, C. L., Abbey, N. W., Sharkey, M. E., Grant, R. M., You, Y., Scarborough, J. D., Ellmeier, W., Littman, D. R., Stevenson, M., Charo, I. F., Herndier, B. G., Speck, R. F., and Goldsmith, M. A., 2002, Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1, J Exp Med. 195:719–736.
Keppler, O. T., Yonemoto, W., Welte, F. J., Patton, K. S., Iacovides, D., Atchison, R. E., Ngo, T., Hirschberg, D. L., Speck, R. F., and Goldsmith, M. A., 2001, Susceptibility of rat-derived cells to replication by human immunodeficiency virus type 1, J Virol. 75:8063–8073.
Klotman, P. E., and Notkins, A. L., 1996, Transgenic models of human immunodeficiency virus type-1, Curr Top Microbiol Immunol. 206:197–222.
Klotman, P. E., Rappaport, J., Ray, P., Kopp, J. B., Franks, R., Bruggeman, L. A., and Notkins, A. L., 1995, Transgenic models of HIV-1, Aids. 9:313–324.
Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C., and Ho, D. D., 1994, Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome, J Virol. 68:4650–4655.
Koutsilieri, E., Sopper, S., Scheller, C., ter Meulen, V., and Riederer, P., 2002, Parkinsonism in HIV dementia, J Neural Transm. 109:767–775.
Leonard, J. M., Abramczuk, J. W., Pezen, D. S., Rutledge, R., Belcher, J. H., Hakim, F., Shearer, G., Lamperth, L., Travis, W., Fredrickson, T., et al., 1988, Development of disease and virus recovery in transgenic mice containing HIV proviral DNA, Science. 242:1665–1670.
Li, J., Lord, C. I., Haseltine, W., Letvin, N. L., and Sodroski, J., 1992, Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins, J Acquir Immune Defic Syndr. 5:639–646.
Livartowski, J., Dormont, D., Boussin, F., Chamaret, S., Guetard, D., Vazeux, R., Lebon, P., Metivier, H., and Montagnier, L., 1992, Clinical and virological aspects of HIV2 infection in rhesus monkeys, Cancer Detect Prev. 16:341–345.
Locher, C. P., Witt, S. A., Herndier, B. G., Tenner-Racz, K., Racz, P., and Levy, J. A., 2001, Baboons as an animal model for human immunodeficiency virus pathogenesis and vaccine development, Immunol Rev. 183:127–140.
Longini, I. M., Jr., Clark, W. S., Byers, R. H., Ward, J. W., Darrow, W. W., Lemp, G. F., and Hethcote, H. W., 1989, Statistical analysis of the stages of HIV infection using a Markov model, Stat Med. 8:831–843.
Luciw, P. A., Shaw, K. E., Unger, R. E., Planelles, V., Stout, M. W., Lackner, J. E., Pratt-Lowe, E., Leung, N. J., Banapour, B., and Marthas, M. L., 1992, Genetic and biological comparisons of pathogenic and nonpathogenic molecular clones of simian immunodeficiency virus (SIVmac), AIDS Res Hum Retroviruses. 8:395–402.
Lusso, P., Markham, P. D., Ranki, A., Earl, P., Moss, B., Dorner, F., Gallo, R. C., and Krohn, K. J., 1988, Cell-mediated immune response toward viral envelope and core antigens in gibbon apes (Hylobates lar) chronically infected with human immunodeficiency virus-1, J Immunol. 141:2467–2473.
Lynn, W. S., and Wong, P. K., 1998, Neuroimmunopathogenesis of ts1 MoMuLV viral infection, Neuroimmunomodulation. 5:248–260.
Marlink, R., Kanki, P., Thior, I., Travers, K., Eisen, G., Siby, T., Traore, I., Hsieh, C. C., Dia, M. C., Gueye, E. H., et al., 1994, Reduced rate of disease development after HIV-2 infection as compared to HIV-1, Science. 265:1587–1590.
McIntyre, J., and Gray, G., 2002, What can we do to reduce mother to child transmission of HIV?, Brit Med J. 324:218–221.
Montagnier, L., 1985, Lymphadenopathy-associated virus: from molecular biology to pathogenicity, Ann Intern Med. 103:689–693.
Montelaro, R. C., Ball, J. M., and Issel, C. J., 1990, Characterization of EIAV immunogenicity during persistent infections: humoral responses and antigen targets, Dev Biol Stand. 72:19–30.
Mosier, D. E., Yetter, R. A., and Morse, H. C., III 1985, Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice, J Exp Med. 161:766–784.
Munoz, A., Wang, M. C., Bass, S., Taylor, J. M., Kingsley, L. A., Chmiel, J. S., and Polk, B. F., 1989, Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. Multicenter AIDS Cohort Study Group, Am J Epidemiol. 130:530–539.
Nara, P. L., Robey, W. G., Arthur, L. O., Asher, D. M., Wolff, A. V., Gibbs, C. J., Jr., Gajdusek, D. C., and Fischinger, P. J., 1987, Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses, J Virol. 61:3173–3180.
Narayan, O., Wolinsky, J. S., Clements, J. E., Strandberg, J. D., Griffin, D. E., and Cork, L. C., 1982, Slow virus replication: the role of macrophages in the persistence and expression of visna viruses of sheep and goats, J Gen Virol. 59:345–356.
Ng, H., 2000, AIDS in Africa: a regional overview, Harv AIDS Rev. 2–5.
Novembre, F. J., Saucier, M., Anderson, D. C., Klumpp, S. A., O’Neil, S. P., Brown, C. R., 2nd, Hart, C. E., Guenthner, P. C., Swenson, R. B., and McClure, H. M., 1997, Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1, J Virol. 71:4086–4091.
Novitsky, V. A., Montano, M. A., McLane, M. F., Renjifo, B., Vannberg, F., Foley, B. T., Ndung’u, T. P., Rahman, M., Makhema, M. J., Marlink, R., and Essex, M., 1999, Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana, J Virol. 73:4427–4432.
Oliver, R. E., Gorham, J. R., Parish, S. F., Hadlow, W. J., and Narayan, O., 1981, Ovine progressive pneumonia: pathologic and virologic studies on the naturally occurring disease, Am J Vet Res. 42:1554–1559.
Oliver, R. E., Gorham, J. R., Perryman, L. E., and Spencer, G. R., 1981, Ovine progressive pneumonia: experimental intrathoracic, intracerebral, and intra-articular infections, Am J Vet Res. 42:1560–1564.
Olmsted, R. A., Barnes, A. K., Yamamoto, J. K., Hirsch, V. M., Purcell, R. H., and Johnson, P. R., 1989, Molecular cloning of feline immunodeficiency virus, Proc Natl Acad Sci USA. 86:2448–2452.
Olmsted, R. A., Hirsch, V. M., Purcell, R. H., and Johnson, P. R., 1989, Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses, Proc Natl Acad Sci USA. 86:8088–8092.
O’Neil, S. P., Novembre, F. J., Hill, A. B., Suwyn, C., Hart, C. E., Evans-Strickfaden, T., Anderson, D. C., deRosayro, J., Herndon, J. G., Saucier, M., and McClure, H. M., 2000, Progressive infection in a subset of HIV-1-positive chimpanzees, J Infect Dis. 182:1051–1062.
Patrick, M. K., Johnston, J. B., and Power, C., 2002, Lentiviral neuropathogenesis: comparative neuroinvasion, neurotropism, neurovirulence, and host neurosusceptibility, J Virol. 76:7923–7931.
Pedersen, N. C., Ho, E. W., Brown, M. L., and Yamamoto, J. K., 1987, Isolation of a Tlymphotropic virus from domestic cats with an immunodeficiency-like syndrome, Science. 235:790–793.
Pedersen, N. C., Yamamoto, J. K., Ishida, T., and Hansen, H., 1989, Feline immunodeficiency virus infection, Vet Immunol Immunopathol. 21:111–129.
Perrin, L., Kaiser, L., and Yerly, S., 2003, Travel and the spread of HIV-1 genetic variants, Lancet Infect Dis. 3:22–27.
Persidsky, Y., Limoges, J., McComb, R., Bock, P., Baldwin, T., Tyor, W., Patil, A., Nottet, H. S., Epstein, L., Gelbard, H., Flanagan, E., Reinhard, J., Pirruccello, S. J., and Gendelman, H. E., 1996, Human immunodeficiency virus encephalitis in SCID mice, Am J Pathol. 149:1027–1053.
Peterman, T. A., Jaffe, H. W., Feorino, P. M., Getchell, J. P., Warfield, D. T., Haverkos, H. W., Stoneburner, R. L., and Curran, J. W., 1985, Transfusion-associated acquired immunodeficiency syndrome in the United States, Jama. 254:2913–2917.
Petersen, L. R., Simonds, R. J., and Koistinen, J., 1993, HIV transmission through blood, tissues, and organs, Aids. 7Suppl 1:S99–107.
Petry, H., and Luke, W., 1997, Infection of macaque monkeys with simian immunodefi-ciency virus: an animal model for neuro-AIDS, Intervirology. 40:112–121.
Phelps, S. L., and Smith, M. C., 1993, Caprine arthritis-encephalitis virus infection, J Am Vet Med Assoc. 203:1663–1666.
Phillips, A. N., 1996, Reduction of HIV concentration during acute infection: independence from a specific immune response, Science. 271:497–499.
Pohlmann, S., Lee, B., Meister, S., Krumbiegel, M., Leslie, G., Doms, R. W., and Kirchhoff, F., 2000, Simian immunodeficiency virus utilizes human and sooty mangabey but not rhesus macaque STRL33 for efficient entry, J Virol. 74:5075–5082.
Putkonen, P., Bottiger, B., Warstedt, K., Thorstensson, R., Albert, J., and Biberfeld, G., 1989, Experimental infection of cynomolgus monkeys (Macaca fascicularis) with HIV-2, J Acquir Immune Defic Syndr. 2:366–373.
Quarto, M., Germinario, C., Fontana, A., and Barbuti, S., 1989, HIV transmission through kidney transplantation from a living related donor, N Engl J Med. 320:1754.
Reid, W., Sadowska, M., Denaro, F., Rao, S., Foulke, J., Jr., Hayes, N., Jones, O., Doodnauth, D., Davis, H., Sill, A., O’Driscoll, P., Huso, D., Fouts, T., Lewis, G., Hill, M., Kamin-Lewis, R., Wei, C., Ray, P., Gallo, R. C., Reitz, M., and Bryant, J., 2001, An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction, Proc Natl Acad Sci USA. 98:9271–9276.
Reinhart, T. A., Rogan, M. J., Huddleston, D., Rausch, D. M., Eiden, L. E., and Haase, A. T., 1997, Simian immunodeficiency virus burden in tissues and cellular compartments during clinical latency and AIDS, J Infect Dis. 176:1198–1208.
Rogers, A. B., Mathiason, C. K., and Hoover, E. A., 2002, Immunohistochemical localization of feline immunodeficiency virus using native species antibodies, Am J Pathol. 161:1143–1151.
Rosenberg, E. S., Billingsley, J. M., Caliendo, A. M., Boswell, S. L., Sax, P. E., Kalams, S. A., and Walker, B. D., 1997, Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia, Science. 278:1447–1450.
Rowe, J. D., and East, N. E., 1997, Risk factors for transmission and methods for control of caprine arthritis-encephalitis virus infection, Vet Clin North Am Food Anim Pract. 13:35–53.
Sakuragi, S., Shibata, R., Mukai, R., Komatsu, T., Fukasawa, M., Sakai, H., Sakuragi, J., Kawamura, M., Ibuki, K., Hayami, M., et al., 1992, Infection of macaque monkeys with a chimeric human and simian immunodeficiency virus, J Gen Virol. 73 (Pt 11):2983–2987.
Salvatori, D., Vincenzetti, S., Maury, G., Gosselin, G., Gaubert, G., and Vita, A., 2001, Maedi-visna virus, a model for in vitro testing of potential anti-HIV drugs, Comp Immunol Microbiol Infect Dis. 24:113–122.
Samuel, D., Castaing, D., Adam, R., Saliba, F., Chamaret, S., Misset, J. L., Montagnier, L., and Bismuth, H., 1988, Fatal acute HIV infection with aplastic anaemia, transmitted by liver graft, Lancet. 1:1221–1222.
Sauermann, U., 2001, Making the animal model for AIDS research more precise: the impact of major histocompatibility complex (MHC) genes on pathogenesis and disease progression in SIV-infected monkeys, Curr Mol Med. 1:515–122.
Sellon, D. C., 1993, Equine infectious anemia, Vet Clin North Am Equine Pract. 9:321–336.
Sellon, D. C., Perry, S. T., Coggins, L., and Fuller, F. J., 1992, Wild-type equine infectious anemia virus replicates in vivo predominantly in tissue macrophages, not in peripheral blood monocytes, J Virol. 66:5906–5913.
Sharp, P. M., Robertson, D. L., and Hahn, B. H., 1995, Cross-species transmission and recombination of “AIDS” viruses, Philos Trans R Soc Lond B Biol Sci. 349:41–47.
Shibata, R., Kawamura, M., Sakai, H., Hayami, M., Ishimoto, A., and Adachi, A., 1991, Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells, J Virol. 65:3514–3520.
Silvotti, L., Corradi, A., Brandi, G., Cabassi, A., Bendinelli, M., Magnani, M., and Piedimonte, G., 1997, FIV induced encephalopathy: early brain lesions in the absence of viral replication in monocyte/macrophages. A pathogenetic model, Vet Immunol Immunopathol. 55:263–271.
Simon, F., Mauclere, P., Roques, P., Loussert-Ajaka, I., Muller-Trutwin, M. C., Saragosti, S., Georges-Courbot, M. C., Barre-Sinoussi, F., and Brun-Vezinet, F., 1998, Identification of a new human immunodeficiency virus type 1 distinct from group M and group O, Nat Med. 4:1032–1037.
Simonds, R. J., 1993, HIV transmission by organ and tissue transplantation, Aids. 7Suppl 2:S35–38.
Smit-McBride, Z., Mattapallil, J. J., McChesney, M., Ferrick, D., and Dandekar, S., 1998, Gastrointestinal T lymphocytes retain high potential for cytokine responses but have severe CD4(+) T-cell depletion at all stages of simian immunodeficiency virus infection compared to peripheral lymphocytes, J Virol. 72:6646–6656.
Speck, R. F., Penn, M. L., Wimmer, J., Esser, U., Hague, B. F., Kindt, T. J., Atchison, R. E., and Goldsmith, M. A., 1998, Rabbit cells expressing human CD4 and human CCR5 are highly permissive for human immunodeficiency virus type 1 infection, J Virol. 72:5728–5734.
Spira, S., Wainberg, M. A., Loemba, H., Turner, D., and Brenner, B. G., 2003, Impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity and drug resistance, J Antimicrob Chemother. 51:229–240.
Straub, O. C., and Levy, D., 1999, Bovine immunodeficiency virus and analogies with human immunodeficiency virus, Leukemia. 13Suppl 1:S106–109.
Sutton, R. E., Coskun, A. K., and Nguyen, V., 2003, Development of a mouse model for HIV/AIDS, Res Initiat Treat Action. 8:22–24.
Tajima, M., Sato, N., Kirisawa, R., Onuma, M., and Maede, Y., 1997, Distribution of bovine immunodeficiency virus in the organs of experimentally infected cows, Jpn J Vet Res. 45:163–167.
Talbott, R. L., Sparger, E. E., Lovelace, K. M., Fitch, W. M., Pedersen, N. C., Luciw, P. A., and Elder, J. H., 1989, Nucleotide sequence and genomic organization of feline immunodeficiency virus, Proc Natl Acad Sci USA. 86:5743–5747.
Tashjian, R. J., 1984, Transmission and clinical evaluation of an equine infectious anemia herd and their offspring over a 13-year period, J Am Vet Med Assoc. 184:282–288.
Tong-Starksen, S. E., Welsh, T. M., and Peterlin, B. M., 1990, Differences in transcriptional enhancers of HIV-1 and HIV-2. Response to T cell activation signals, J Immunol. 145:4348–4354.
UNAIDS/WHO, 2003, in Trop Doct, Geneva, pp. 1–48.
Unutmaz, D., KewalRamani, V. N., and Littman, D. R., 1998, G protein-coupled receptors in HIV and SIV entry: new perspectives on lentivirus-host interactions and on the utility of animal models, Semin Immunol. 10:225–236.
Vella, C., and Daniels, R. S., 2003, CD8+ T-cell-mediated non-cytolytic suppression of human immuno-deficiency viruses, Curr Drug Targets Infect Disord. 3:97–113.
Vento, S., Di Perri, G., Garofano, T., Concia, E., and Bassetti, D., 1993, Pneumocystis carinii pneumonia during primary HIV-1 infection, Lancet. 342:24–25.
Villet, S., Bouzar, B. A., Morin, T., Verdier, G., Legras, C., and Chebloune, Y., 2003, Maedivisna virus and caprine arthritis encephalitis virus genomes encode a Vpr-like but no Tat protein, J Virol. 77:9632–9638.
Vodros, D., Thorstensson, R., Biberfeld, G., Schols, D., De Clercq, E., and Fenyo, E. M., 2001, Coreceptor usage of sequential isolates from cynomolgus monkeys experimentally infected with simian immunodeficiency virus (SIVsm), Virology. 291:12–21.
Watson, R. R., 1989, Murine models for acquired immune deficiency syndrome, Life Sci. 44:iii–xv.
WHO, 1990, Report of a WHO informal consultation on animal models for evaluation of drugs and vaccines for HIV infection and AIDS. W.H.O., Geneva, 14–15 September 1989, Biologicals. 18:225–233.
Wofsy, C. B., Cohen, J. B., Hauer, L. B., Padian, N. S., Michaelis, B. A., Evans, L. A., and Levy, J. A., 1986, Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus, Lancet. 1:527–529.
Wong, P. K., Prasad, G., Hansen, J., and Yuen, P. H., 1989, ts1, a mutant of Moloney murine leukemia virus-TB, causes both immunodeficiency and neurologic disorders in BALB/c mice, Virology. 170:450–459.
Yang, O. O., Kalams, S. A., Trocha, A., Cao, H., Luster, A., Johnson, R. P., and Walker, B. D., 1997, Suppression of human immunodeficiency virus type 1 replication by CD8+cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms, J Virol. 71:3120–3128.
Yokomaku, Y., Miura, H., Tomiyama, H., Kawana-Tachikawa, A., Takiguchi, M., Kojima, A., Nagai, Y., Iwamoto, A., Matsuda, Z., and Ariyoshi, K., 2004, Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection, J Virol. 78:1324–1332.
Zenger, E., Tiffany-Castiglioni, E., and Collisson, E. W., 1997, Cellular mechanisms of feline immunodeficiency virus (FIV)-induced neuropathogenesis, Front Biosci. 2:d527–537.
Zink, M. C., Yager, J. A., and Myers, J. D., 1990, Pathogenesis of caprine arthritis encephalitis virus. Cellular localization of viral transcripts in tissues of infected goats, Am J Pathol. 136:843–854.
Zuber, B., Bottiger, D., Benthin, R., ten Haaft, P., Heeney, J., Wahren, B., and Oberg, B., 2001, An in vivo model for HIV resistance development, AIDS Res Hum Retroviruses. 17:631–635.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Anderson, E.R., Xiong, H., Gendelman, H.E. (2006). Animal Model Systems of HIV-Diseases. In: Friedman, H., Specter, S., Bendinelli, M. (eds) In vivo Models of HIV Disease and Control. Infectious Diseases and Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/0-387-25741-1_2
Download citation
DOI: https://doi.org/10.1007/0-387-25741-1_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-25740-2
Online ISBN: 978-0-387-25741-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)